Ergo Science ROE 1971-1970 | ERGN

Current and historical return on equity (ROE) values for Ergo Science (ERGN) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Ergo Science ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
Sector Industry Market Cap Revenue
Business Services Business Information Services $0.000B $0.000B
ERGO SCIENCE CORP. is developing novel treatments for metabolic and immune system disorders including Type II diabetes and obesity.
Stock Name Country Market Cap PE Ratio
Recruit Holdings (RCRUY) Japan $90.398B 32.29
Experian (EXPGY) Ireland $48.683B 0.00
Verisk Analytics (VRSK) United States $42.321B 44.82
Iron Mountain (IRM) United States $29.383B 56.27
TransUnion (TRU) United States $18.094B 25.98
FactSet Research Systems (FDS) United States $16.808B 26.68
Morningstar (MORN) United States $12.835B 36.25
INTERTEK GP (IKTSY) United Kingdom $10.311B 0.00
Dun & Bradstreet Holdings (DNB) United States $4.071B 10.36
National Research (NRC) United States $0.384B 16.38
YSX Tech (YSXT) China $0.118B 0.00
UCloudlink Group (UCL) Hong Kong, SAR China $0.071B 21.00
Click Holdings (CLIK) Hong Kong, SAR China $0.013B 0.00
36Kr Holdings (KRKR) China $0.011B 0.00